Biotech VC Funds

Mindset Ventures is an early-stage venture capital firm with a focus on B2B tech startups in sectors like fintech, cybersecurity, agriculture, healthcare, and enterprise software. The firm primarily invests in the U.S. and Israel, but its roots in Brazil make it a powerful gateway for companies expanding into Latin America. Mindset is known for its strategic support, offering portfolio companies access to key business development opportunities, especially in the Brazilian market. Notable investments include Turing, PayJoy, and Pecan, where the fund has been pivotal in helping these companies with international growth. Mindset's investment strategy combines agility with thorough due diligence, often co-investing alongside top-tier VCs. They generally target early-stage startups with tickets ranging from $1 million to $5 million and prefer companies with coachable founders open to strategic guidance. Co-founded by Daniel Ibri, who leads from São Paulo, the team is well-versed in international expansion, helping companies scale beyond their initial markets. For startups seeking funding, Mindset values transparency and expects a well-researched approach that highlights how founders plan to scale globally.

Mirae Asset Venture Investments is the venture capital arm of Mirae Asset Financial Group, a global financial services giant headquartered in South Korea. The venture fund focuses on early to growth-stage investments, particularly in the technology, life sciences, fintech, and consumer sectors. Their portfolio features prominent companies like Unacademy, Ola, Zomato, and Bigbasket, reflecting their strong interest in emerging markets and digital platforms. Geographically, the fund has a significant presence across Asia, particularly in India and Southeast Asia, as well as North America. Mirae Asset employs a long-term, research-driven investment strategy, often co-investing with other prominent VC firms like SIG Venture Capital and Peak XV Partners. They have been especially active in 2024, making several key investments across various sectors, including fintech startup Jupiter and online grocery platform HappyFresh. With a focus on strategic growth, they seek companies that can redefine industries or introduce innovative solutions, and provide not just capital but also robust portfolio management. Their team, led by key executives like Ashish Dave in India, supports portfolio companies with deep market insights and hands-on guidance​.

Miroma Ventures is the investment arm of The Miroma Group, focusing primarily on venture and growth-stage investments in consumer brands and media platforms. Based in London, the firm leverages the extensive marketing expertise and global network of The Miroma Group to accelerate the growth of its portfolio companies. This unique approach allows Miroma Ventures to offer a mix of capital investment and tailored marketing services, making them a strategic partner for companies looking to expand their reach and scale rapidly. Miroma Ventures typically invests in the Seed, Series A, and Series B stages, with investment sizes ranging from $250,000 to $5 million. The firm is known for its interest in sectors like food and beverage, beauty and personal care, e-commerce, and digital media. They also offer flexible financing solutions, such as media services in exchange for equity, combining both financial and marketing support. The company has backed over 50 brands globally, including well-known names like ClassPass and Pinterest, reflecting its strong track record in the consumer and media industries. Miroma Ventures is particularly interested in partnering with businesses that show strong growth potential and can leverage its marketing expertise to build long-term value. With its focus on purpose-driven investments and consumer engagement, Miroma Ventures continues to support innovative brands that connect with modern audiences while fostering substantial growth.

Mission Bay Capital is a venture capital firm based in San Francisco, focused on early-stage investments in the biosciences. Established in 2009, the firm aims to support innovative entrepreneurs addressing critical medical and environmental challenges. Their portfolio includes companies like Caribou Biosciences, Alector, Zymergen, and Mammoth Biosciences, which utilize cutting-edge technologies such as CRISPR for molecular diagnostics​​. The firm has recently raised its third fund, totaling $60 million, which will continue to invest broadly in biotechnology innovations. Mission Bay Capital operates MBC BioLabs, a life-science incubator that has helped launch 138 companies, raising over $3.5 billion in total. This incubator provides state-of-the-art equipment and services to early-stage biotech companies, enabling them to advance their research and development efficiently​. Mission Bay Capital is led by Douglas Crawford, Ph.D., along with a team of experienced professionals like Robert Blazej, Ph.D. They emphasize disciplined investing and a management culture rooted in respect and inclusion, aiming to deliver superior returns and strategic opportunities to their limited partners​.

Mission BioCapital, founded in 2009, is a venture capital firm that focuses on early-stage investments in life sciences companies. With offices in Cambridge, Massachusetts, and San Francisco, California, the firm supports startups from the idea phase through to key development milestones. Mission BioCapital emphasizes collaboration and innovation, providing capital and strategic support to help scientific solutions reach the clinic faster and more efficiently. The firm recently announced raising $275 million for its fifth fund, Mission BioCapital V, which is aimed at funding transformative startups in therapeutics, diagnostics, medical devices, laboratory tools, and drug delivery. This fund also emphasizes company creation, working with academic researchers and entrepreneurs to launch startups based on novel technologies. Notable portfolio companies include Caribou Biosciences, Effector Therapeutics, and Alector, with several successful exits and IPOs. Mission BioCapital has also co-founded companies like ARase Therapeutics, Arclight Therapeutics LLC, Jupiter Bioventures, and Telo Therapeutics, demonstrating its deep involvement in nurturing groundbreaking life science ventures. The team at Mission BioCapital includes experienced professionals like Dr. Michael D. Taylor, who has a significant background in drug development at Pfizer and startups like Deciphera Pharmaceuticals. Co-Managing Partner Steve Tregay also brings extensive experience from his tenure at FORMA Therapeutics and the Novartis Venture Fund.

Mistletoe, a venture capital firm based in Kanazawa, Japan, was founded by Taizo Son and Atsushi Taira in 2013. The fund focuses on early-stage investments in tech-driven startups with a strong emphasis on sustainability and social impact. Notable investments include Zipline, Playco, and Sea, reflecting their commitment to innovative and impactful ventures. Mistletoe's industry focus spans across biotechnology, clean energy, health tech, and entertainment, showing a diverse portfolio aimed at transformative technologies. Geographically, their investments are global, covering North America, Asia, and Europe, with recent activities in countries like Japan, the U.S., and Finland. Their strategy revolves around partnering with visionary founders who tackle global challenges. Mistletoe typically invests in seed to series A stages, often leading rounds with an average check size of around $2 million. They have a collaborative approach, frequently co-investing with firms like Sequoia Capital and Plug and Play Tech Center. Active in fostering an ecosystem of like-minded investors and entrepreneurs, Mistletoe values innovation and societal contributions highly. The team, including key members like Michael Kim and Satoshi Fujimura, is primarily based in Japan with a significant presence in Singapore. Startups looking to engage with Mistletoe should emphasize their mission-driven goals and innovative solutions. Approaching them through warm introductions and clear, impactful pitches increases the chances of successful engagement​.

Mithril Capital, founded in 2012 by Ajay Royan and Peter Thiel, is a venture capital firm based in Austin, Texas. The firm focuses on long-term investments across various sectors and geographies, partnering with teams that leverage technology to create lasting and valuable businesses. Mithril's investment philosophy emphasizes broadminded curiosity, capital discipline, and constructive skepticism, seeking to support industries that are ripe for technological disruption. Mithril's portfolio includes notable companies such as Helion Energy, which is pioneering fusion energy; Neocis, which is advancing robotics in dental surgery; and Glance, a rapidly growing consumer internet platform. Other significant investments include Nuvia (acquired by Qualcomm), Auris Health (acquired by Johnson & Johnson), and BlackSky, a leader in real-time geospatial intelligence. The firm prides itself on helping companies navigate critical growth inflection points, supporting them with strategic insights and substantial capital investments. This approach has enabled Mithril's portfolio companies to achieve remarkable advancements in their respective fields, from reshaping robotic surgery to revolutionizing decentralized finance and enhancing grid resilience with AI-driven energy storage solutions.

Mitsui & Co., a leading global trading and investment company, has a diverse portfolio across multiple industries. Founded in 1876 and headquartered in Tokyo, Mitsui has expanded its operations globally, focusing on sectors such as energy, healthcare, technology, and consumer goods. Notable investments by Mitsui & Co. include Lhyfe, a French company specializing in renewable green hydrogen production, aligning with Mitsui’s commitment to sustainable energy solutions. QurAlis, a biotechnology company, is developing precision medicines for ALS and other neurodegenerative diseases. Leash Biosciences is an AI-driven biotech firm revolutionizing medicinal chemistry. Kaltura, a leading video technology provider, went public through an IPO. Virident, a high-performance storage class memory solutions company, was acquired. Boston Biomedical focuses on novel cancer treatments. Proterra, a manufacturer of zero-emission vehicles, merged through a SPAC. Mitsui & Co. leverages its global network and industry expertise to support innovative companies and foster growth in various sectors.

Miyako Capital, established in 2013 and affiliated with Kyoto University, is a prominent venture capital firm based in Kyoto, Japan, with additional offices in Tokyo and Silicon Valley. The firm focuses on early-stage investments in deep-tech sectors such as biotechnology, artificial intelligence, robotics, healthcare, energy, and more. Notable investments by Miyako Capital include Sakana AI, Orange, and Viage Therapeutics. The firm has recently launched its third deep tech fund, Miyako Kyoto University Innovation No. 3 Investment Limited Partnership, aiming to raise JPY 20 billion (approximately USD 140 million) to support cutting-edge startups. This fund is part of their broader strategy to bolster deep tech innovation and facilitate global expansion for their portfolio companies​. Led by experienced venture capitalists like Yasuhiro Yamaguchi and Tsunesaburo Sugaya, Miyako Capital leverages its strong ties to academic institutions to identify and nurture groundbreaking technologies. The firm has a track record of backing research-driven startups, contributing significantly to Japan's deep tech landscape.

Mizuho Bank, a core subsidiary of Mizuho Financial Group, operates as a global financial services provider with an extensive network of over 505 branches in Japan and 38 other countries. Headquartered in Tokyo, Mizuho is a prominent player in both retail and corporate banking sectors. The bank’s name, meaning "golden ears of rice," signifies prosperity and growth. Mizuho Bank has a diverse investment portfolio and notable investments include a significant stake in Vietnam's leading digital payment company, M-Service, which showcases its focus on expanding digital financial services in emerging markets. The bank has also been involved in several high-profile M&A deals globally, leveraging its strong expertise in structured finance and equity underwriting. Mizuho's strategy emphasizes building long-term relationships with clients by offering tailored financial solutions that include equity and bond financing, M&A advisory services, and structured finance. The bank has also made substantial efforts to lead in sustainable finance, integrating ESG factors into its investment decisions and operations. Key members of Mizuho’s leadership, including CEO Koji Fujiwara, bring a wealth of experience and strategic vision, guiding the bank’s initiatives in innovative financial services and global expansion. For businesses seeking investment, Mizuho’s approach is to provide comprehensive support through its extensive global network and deep industry insights, making it a reliable partner for growth and sustainability​.

MMC Ventures is a London-based venture capital firm that has been supporting early-stage tech entrepreneurs for over 20 years. Focused on transformative technology, MMC specializes in sectors such as artificial intelligence (AI), data-driven health, fintech, and enterprise software. The firm has built a reputation for deep industry expertise, particularly in AI and data science, where it is one of Europe's most active investors. Notable investments include Synthesia, Signal AI, and Current Health, the latter of which was acquired by Best Buy. MMC’s investment strategy is research-led, with a dedicated team of specialists who help identify and develop cutting-edge technologies. They typically invest in Seed and Series A rounds, but a significant portion of their funds is reserved for follow-on rounds, ensuring long-term support for portfolio companies. MMC also places a strong emphasis on partnering closely with founders, providing more than just capital; they offer resources like MMC Connect, a platform that facilitates introductions, coaching, and talent acquisition. In recent years, MMC has expanded its portfolio across Europe, backing companies in markets from the UK to Eastern Europe. The firm is committed to building businesses with the potential to drive technological advancements and create a positive impact on society, as evidenced by its status as one of the first B Corporations in venture capital.

Mobile Internet Capital (MIC), established in 1999, is a venture capital firm based in Japan. The firm focuses on investing in innovative technology companies with a strong emphasis on internet and mobile-related sectors. MIC has a successful track record with 22 IPOs and numerous exits. Their portfolio includes companies like Gree, a social networking service provider, and Mercari, a popular marketplace app. MIC invests in early to growth-stage companies, supporting them through multiple rounds to help them achieve significant milestones and market expansion. MIC is known for its strategic approach, leveraging its deep industry knowledge and network to provide not only capital but also valuable guidance and connections to its portfolio companies. They aim to foster long-term growth and innovation in the tech industry.

Molten Ventures, formerly known as Draper Esprit, is a leading venture capital firm based in London, with additional offices in Cambridge and Dublin. The firm focuses on investing in high-growth technology companies across Europe. Since its inception in 2006, Molten Ventures has built a diverse portfolio with significant investments in sectors like consumer technology, digital health and wellness, AI, deep tech, hardware, cloud, enterprise, and SaaS. Notable investments by Molten Ventures include Trustpilot, UiPath, Graphcore, Revolut, and Aircall. These investments highlight the firm’s emphasis on supporting innovative companies with strong potential for global impact and scalable growth. Molten Ventures typically invests from Series A onwards, providing substantial follow-on funding to support companies throughout their growth stages. Molten Ventures manages over £1.5 billion in assets and has invested in over 340 companies, making it one of the most active and influential VC firms in Europe. Their investment strategy involves combining three pools of capital—PLC, EIS, and VCT vehicles—to support a broad range of high-potential tech startups. The firm places a strong emphasis on sustainability and ESG, having integrated these principles into their investment process and company culture. Key figures at Molten Ventures include CEO Martin Davis and CFO Benjamin Wilkinson, who lead a team dedicated to identifying and nurturing transformative tech startups. The firm has also completed successful exits from companies like SportPursuit, Premfina, Conversocial, and Bright Computing.

Momenta is a leading venture capital firm specializing in Industrial Impact investments, focusing on digital innovators in sectors such as energy, manufacturing, smart spaces, and supply chain. They have a decade-long track record of scaling companies that drive significant industrial and environmental improvements. Notable portfolio companies include Tvarit, Fleet Space, FreeWire, and EquipmentShare, which reflect their emphasis on impactful, scalable technologies. Momenta's investment strategy involves early-stage funding and close collaboration with founders to foster business growth. They leverage a robust network of industrial partners and extensive industry experience to support their portfolio companies, offering more than just financial backing. Their approach includes strategic advice, connections to potential customers and partners, and assistance with market positioning and scaling operations. Geographically, Momenta operates across Europe and North America, with key team members based in cities like Seattle, Luzern, and San Francisco. The team includes experienced professionals like Michael Dolbec and Douglas Harp, who bring decades of expertise in digital transformation, industrial IoT, and strategic business development. Startups seeking investment should demonstrate innovative solutions with the potential for significant industrial impact. Momenta values strong leadership teams and scalable business models that align with their mission of driving digital transformation and sustainability in critical industries.

Monk's Hill Ventures, founded in 2014 by entrepreneurs Peng T. Ong and Kuo-Yi Lim, is a prominent venture capital firm based in Singapore. The firm focuses on early-stage investments, particularly pre-Series A and Series A, in Southeast Asia. Their portfolio includes over 50 high-growth tech companies across various sectors such as healthtech, fintech, edtech, e-commerce, and logistics. Some notable investments from Monk's Hill Ventures include Ninja Van, an app-based platform for last-mile delivery services; KKday, a platform for booking outdoor tours; and Glints, an online job board platform for graduates. Additionally, they have invested in companies like ELSA Speak, a mobile application for improving English speaking skills, and Waresix, an on-demand warehousing service provider. Monk's Hill Ventures supports its portfolio companies by providing not only capital but also entrepreneurial expertise and a strong network to help founders scale their businesses. They typically look for strong business fundamentals and sizable market opportunities in the companies they invest in, making only a select number of investments each year to ensure they can fully commit to their founders' success. The leadership team, including co-founders Peng T. Ong and Kuo-Yi Lim, brings extensive experience in building and investing in tech companies, reinforcing the firm's mission to empower Southeast Asia's most ambitious tech entrepreneurs.

Montage Ventures, headquartered in Menlo Park, California, is an early-stage venture capital firm that focuses on investments in the fintech, e-commerce, and healthcare sectors. The firm is renowned for backing innovative startups that challenge the status quo, including notable companies like MoneyLion, a digital bank aimed at the middle class, and PeerStreet, a tech-enabled real estate investment platform. Montage Ventures typically invests in the gap between Angel and Series A rounds, with an average investment size around $2M. They are involved in 7-12 deals per year, preferring to co-invest alongside other venture firms rather than leading rounds. The fund is particularly active in the United States, with significant investments in both the East and West Coasts. The firm’s strategy emphasizes supporting technical founders with deep industry knowledge and scalable solutions. Montage Ventures looks for startups with clear market demand and strong potential for growth. They prefer warm introductions and value detailed pitch decks that outline a clear business model and growth strategy. Startups looking to connect with Montage Ventures should demonstrate a robust product-market fit and innovative solutions within fintech, e-commerce, or healthcare. Their proactive and collaborative approach makes them a preferred partner for early-stage companies aiming for transformative impact.

Moonshots Capital is a seed-stage venture capital firm founded in 2017, with offices in Los Angeles and Austin. The firm focuses on investing in companies led by extraordinary leaders, particularly those who are military veterans or serial entrepreneurs. The co-founders, Kelly Perdew and Craig Cummings, leverage their extensive military and entrepreneurial experience to provide more than just capital to their portfolio companies, offering strategic guidance, operational support, and a vast network of contacts. Notable investments by Moonshots Capital include Slack, Robinhood, ID.me, and Bitium. The firm has a diverse portfolio that spans various sectors such as fintech, cybersecurity, consumer internet, and web3 technologies. Moonshots Capital takes an active role in the companies they invest in, often taking board seats or formal advisory roles to ensure they can provide maximum support and value. The firm's investment strategy prioritizes companies with strong leadership, a proven track record, and the potential for high growth. Moonshots Capital typically invests in companies that have a product with client traction, monthly recurring revenue of at least $100,000, and have raised at least $500,000 in previous funding rounds. They are particularly interested in companies at the seed or Series A stage that have a clear path to the next round of financing.

Morado Ventures is a venture capital firm focused on seed-stage investments, partnering with passionate entrepreneurs who tackle complex technological problems using both software and hardware solutions. Their current focus areas include Artificial Intelligence, Data Infrastructure, Industrial Internet, Robotics & Autonomy, Computer Vision, and Health. Founded by Ash Patel and Mike Marquez, Morado Ventures brings extensive experience in leading and investing in technology companies. Ash Patel, a former senior executive at Yahoo!, and Mike Marquez, with a background in corporate development at CBS Interactive and Yahoo!, co-founded the firm to leverage their expertise in identifying and nurturing promising startups. Morado Ventures' investment philosophy emphasizes supporting early-stage, data-fueled companies capable of solving significant challenges in industries ripe for disruption. They actively collaborate with founders to develop and execute successful strategies, providing access to a network of seasoned professionals and resources. Their portfolio includes a diverse range of companies such as Lucid Lane, Tensorfield Agriculture, and Cargomatic, reflecting their commitment to fostering innovation across various sectors.

MoreVC, founded in 2006, is a prominent Israeli venture capital firm specializing in seed and early-stage technology startups. The firm focuses on diverse sectors, partnering with entrepreneurs who are building impactful companies. Notable investments include Vayyar, WeissBeerger, Claroty, and Freightos, showcasing their commitment to innovative and scalable technologies across industries such as cybersecurity, imaging, and logistics​. MoreVC manages several funds, with investments typically ranging from pre-seed to Series A stages. They emphasize strong partnerships with entrepreneurs, providing not just capital but also strategic guidance and a robust network. The firm is known for its founder-friendly approach, often praised for its values and smart advice by portfolio companies. The leadership team, including founding partners Meir Ukeles, Glen Schwaber, and Elliott Sussman, brings extensive experience from various fields such as technology, finance, and public policy. Their combined expertise allows MoreVC to effectively support startups in navigating complex markets and achieving growth.

Morningside Group is a venture capital and private equity firm founded in 1986 and headquartered in Newton, Massachusetts. The firm focuses on investing in early-stage companies across various sectors, including biotechnology, consumer electronics, hardware, artificial intelligence, and fintech. Morningside is known for its long-term investment outlook and commitment to supporting innovative and impactful ventures. Notable investments in Morningside's portfolio include Cognoa, Sensel, The Nue Co., Homee, and Prescryptive Health. These investments highlight Morningside's focus on cutting-edge technology and healthcare solutions. The firm has made over 190 investments and has seen more than 30 successful exits, demonstrating its effectiveness in nurturing high-growth companies. Morningside operates globally, with significant investments in the United States and China, and has a diversified portfolio that includes companies like Evonetix in the biotech sector and Wiseconn in agtech. The firm is active in both seed and later-stage investments, providing substantial capital and strategic support to its portfolio companies.

Morningstar Ventures is a Dubai-based venture capital firm founded in 2020 by Danilo Carlucci and Arutyun Nazaryan. The firm focuses on investing in blockchain, digital assets, Web3, and decentralized finance (DeFi). With a portfolio spanning 199 investments, Morningstar has backed notable companies such as Unstoppable Domains and Axelar, both of which have achieved unicorn status. The firm typically participates in early-stage funding, ranging from Seed to Series A rounds, with investments averaging between $1 million to $5 million. Morningstar Ventures stands out for its deep involvement in the growth of its portfolio companies, providing not only capital but also strategic support and access to its vast network in the crypto and blockchain industries. In addition to its investment activities, Morningstar operates MSV GG, an initiative that supports Web3 startups by providing them with industry expertise and marketing resources. This holistic approach allows Morningstar to align closely with the companies it invests in, helping them scale rapidly in the competitive blockchain space. With its headquarters in Dubai, the firm has expanded its influence across various regions, focusing on fostering the next generation of decentralized technologies and contributing to the global adoption of blockchain​.

Morpheus Ventures, founded in 2016 and based in Los Angeles, focuses on early-stage investments in cutting-edge technologies such as data analytics, machine learning, robotics, and SaaS. Their portfolio includes innovative companies like Rigetti Computing, Vicarious, and Starship Technologies. The firm has made significant exits including Rigetti Computing and Vicarious (acquired by Alphabet). Other notable investments include HouseCanary, a real estate data analytics company, SafetyCulture, a leading safety and quality inspection software, and Sidecar Health, a health insurance platform. The leadership team at Morpheus Ventures includes experienced investors like Damien Petty, who has a background in artificial intelligence, robotics, and quantum computing, and has led investments in companies like DeepMind (acquired by Google) and Skype (acquired by Microsoft). The team focuses on identifying and nurturing companies with the potential to disrupt their respective industries and drive significant advancements in technology.

MTN Group is a leading telecommunications company based in Johannesburg, South Africa. The company has a strong presence across Africa and the Middle East, serving over 289 million subscribers. MTN Group's investment arm has made notable investments in sectors such as telecom infrastructure, renewable energy technology, and horizontal e-commerce. Key investments include companies like Fenix International, a renewable energy company acquired by ENGIE, and Jumia, a leading e-commerce platform in Africa. Another significant investment is in IHS Towers, one of the largest independent owners, operators, and developers of shared telecommunications infrastructure. MTN Group has committed substantial funds towards infrastructure projects to enhance its service delivery. For instance, it pledged $215 million for infrastructure investment in Benin over three years, focusing on building a state-of-the-art office for MTN Benin and expanding digital solutions across the region. Financially, MTN Group has reported strong performance with a 23.4% return on equity and a 10% increase in dividends to 330 cents per share. The group's strategic focus includes expanding its fintech ecosystem, investing in network infrastructure, and promoting digital inclusion across its markets.

Moving Capital, now known as Karman Ventures, is a venture capital firm founded by Uber alumni to support startups with innovative solutions. The firm has made notable investments across various sectors, including aerospace, artificial intelligence, retail technology, and green technology. Noteworthy investments by Karman Ventures include Whisper Aero, a company focusing on aerospace and green technology; Luca, which specializes in AI-driven retail technology; and Regent, which develops electric vehicles for marine transportation. Other significant investments are in companies like Gigs, focusing on mobile applications, and Kasa Living, a hospitality tech company. Karman Ventures is based in Austin, Texas, and has a strong network of co-investors, including prominent firms like Y Combinator, Menlo Ventures, and LaunchTN. Their investment strategy typically involves supporting companies from seed to growth stages, emphasizing scalable and transformative technologies.

Moxxie Ventures is a venture capital firm founded in 2019 by Katie Jacobs Stanton, a former Twitter executive and co-founder of the #ANGELS investment collective. The firm is based in Mountain View, California, with a secondary office in Boulder, Colorado. Moxxie Ventures focuses on early-stage investments, particularly in consumer, enterprise, fintech, healthtech, and climate sectors. Moxxie Ventures recently closed its second fund at $85 million, a significant increase from its inaugural $25 million fund. The firm typically writes checks ranging from $250,000 to $500,000 and aims to make 10 to 12 investments per year, reserving half of the fund for follow-on investments. Notable investors backing Moxxie Ventures include Bain Capital Ventures, Bloomberg Beta, Foundry Group, and individual investors such as Marc Andreessen, Susan Wojcicki, and Jerry Yang. The firm prides itself on bringing a combination of capital, operating experience, and a strong network to its portfolio companies. Stanton and her team leverage their extensive backgrounds in product, engineering, marketing, and business development to support founders in scaling their businesses. Moxxie Ventures is committed to partnering with founders who are passionate about making life and work better through innovative solutions. Some of their notable investments include companies like Elpha, Carta, and Clubhouse. The firm continues to build on its mission to support founders with not just funding but also strategic guidance and connections to a broad network of industry experts and leaders.

MPM Capital, founded in 1997, is a leading venture capital firm based in Boston and San Francisco, specializing in biotechnology and life sciences investments. The firm has a robust portfolio, having invested in over 150 companies, including notable names like 23andMe, ReNAgade Therapeutics, and Argenx. MPM Capital's focus is on transforming innovative scientific discoveries into breakthrough medicines, particularly in oncology and other high-need therapeutic areas​. MPM Capital recently raised $850 million for its second Oncology Impact Fund, marking it as one of the largest biotech impact investment funds globally. This fund emphasizes investments in companies developing novel cancer therapies, reflecting MPM's deep commitment to addressing significant medical challenges. The firm's team includes seasoned professionals with extensive experience in research, drug development, and corporate strategy. Key team members like Dr. Luke Evnin and Dr. Ansbert Gadicke bring invaluable expertise to the firm, guiding its strategic investments and supporting portfolio companies through various growth stages​ .

Mubadala Capital’s Ventures platform stands out as a leading global investor, blending the strengths of Mubadala Investment Company with the agility of a venture capital firm. Focused on technology and healthcare sectors, Mubadala has made over 75 investments, including notable startups like Chroma Medicine, Recursion Pharmaceuticals, and Exscientia. Their strategy revolves around partnering with visionary founders to build enduring companies, leveraging Mubadala’s extensive resources and global scale. Geographically, Mubadala Ventures operates with a significant presence in technology hubs such as San Francisco, London, and Abu Dhabi, ensuring deep integration into the global innovation ecosystem. They emphasize Series A+ investments in the U.S. and Series B+ in Europe, providing substantial capital and strategic support to their portfolio companies. Mubadala's investment strategy is marked by a focus on capital preservation and downside protection, ensuring sustainable growth and returns. The fund typically invests in founder-led companies, with average check sizes tailored to the needs of each growth stage. They are known for their disciplined approach to evaluating opportunities, benefiting from Mubadala's broad network and sovereign backing. The team at Mubadala Ventures includes industry veterans like Ibrahim Ajami, Head of Ventures, and Alaa Halawa, Co-Head of US Ventures. Their expertise spans various sectors and geographies, further strengthening Mubadala’s investment acumen. Startups looking to engage with Mubadala are advised to highlight their alignment with Mubadala’s strategic focus and demonstrate robust business models that can benefit from Mubadala’s vast resources and network.

Mucker Capital, founded in 2012 and headquartered in Los Angeles, is a venture capital firm that invests in seed and early-stage startups across the United States, Canada, and beyond. With additional offices in Austin and Toronto, Mucker Capital focuses on internet-enabled software and services, aiming to support startups outside the traditional Silicon Valley ecosystem. The firm believes that great companies can be built anywhere and provides tactical help, networking opportunities, and a bridge to Silicon Valley resources. Notable portfolio companies include Honey, acquired by PayPal; Surf Air, which went public on NASDAQ; and ServiceTitan, a business management software for home service providers. Mucker Capital has also backed companies like The Black Tux, ServiceTitan, and BloomNation. MuckerLab, their pre-seed accelerator, is highly regarded and ranked second in the U.S. by the Seed Accelerator Rankings Project based on valuations, exits, fundraising, survival, and founder satisfaction. Mucker Capital's approach includes rolling up their sleeves to work alongside entrepreneurs on product development, marketing, sales, recruiting, and other critical areas to help startups succeed. The firm has launched multiple funds, including Mucker III, a $45 million seed-stage fund, and continues to support the growth and scaling of innovative startups.

Muse Capital is an early-stage venture capital fund based in Los Angeles, California, focused on investing in consumer-facing startups. Founded in 2016, the firm aims to bridge the gap between Silicon Valley, the entertainment industry, and the corporate sector, providing strategic capital and partnership-based business development. Muse Capital has a diverse portfolio that includes companies like CoFertility, Beekeeper's Naturals, Cloud Paper, and Firefly, all of which are pushing boundaries in telehealth, education, motherhood, gaming, and underserved markets. The firm is led by Assia Grazioli-Venier and Rachel Springate, who leverage their extensive networks in the entertainment and corporate worlds to support their portfolio companies. Muse Capital typically invests in seed-stage rounds, providing both financial backing and strategic guidance to help startups grow and succeed. Muse Capital is particularly known for its active involvement in the companies it invests in, offering tactical insights and connections to key industry players. This hands-on approach has made Muse a valuable partner for entrepreneurs looking to disrupt and innovate within the consumer sector. For startups looking to engage with Muse Capital, demonstrating a clear vision for consumer impact and leveraging the firm’s entertainment and corporate connections can be crucial.

MVM Partners, founded in 1997, is a global venture capital firm focused on high-growth healthcare investments. With offices in Boston and London, MVM invests broadly across sectors including medical technology, pharmaceuticals, diagnostics, digital health, and other healthcare-related fields. Their portfolio includes notable companies such as SkyCell, which developed patented temperature-control technology for safely transporting vaccines and biotech drugs, and Ossio, which created OSSIOfiber Intelligent Bone Regeneration Technology—a novel orthopedic fixation material that integrates into native bone and avoids the need for permanent metal implants. MVM also invested in MDxHealth, a company specializing in molecular diagnostics for urologic cancers, which enhances personalized cancer diagnosis and treatment. MVM's investment strategy emphasizes significant minority stakes in innovative companies, providing both financial support and strategic guidance to help these companies grow and scale. Their approach involves close collaboration with management teams to drive business development and market expansion. MVM's recent investments include companies like eXmoor Pharma, which focuses on cell and gene therapy services, and Nalu Medical, which develops minimally invasive solutions for chronic pain management. These investments reflect MVM's commitment to supporting advancements in medical technology and improving patient outcomes globally.

My Climate Journey Collective (MCJ Collective) is a venture capital firm dedicated to investing in innovative climate solutions. Founded to drive significant impact in combating climate change, MCJ Collective supports early-stage startups across a range of sectors including renewable energy, mobility, food systems, and sustainable infrastructure. MCJ Collective's portfolio includes notable companies such as BlocPower, which focuses on clean energy and smart city solutions, and Arcadia, a technology company democratizing access to clean energy. They have also invested in Enode, a developer of APIs for information services, and Hoxton Farms, a biotechnology company working on sustainable food solutions. The firm is known for its broad investment strategy, backing startups that aim to mitigate climate change and improve environmental sustainability. They have a strong focus on sectors like renewable energy, electrification, carbon management, and the built environment. MCJ Collective emphasizes the importance of technological innovation in addressing climate challenges, supporting companies that leverage AI, data centers, and other advanced technologies. The team at MCJ Collective includes experienced professionals with a deep understanding of climate issues and investment strategies, ensuring that they provide not only capital but also strategic guidance to their portfolio companies. For more detailed information, you can explore their portfolio and insights on their official.

Mystic Ventures, founded in 2021 and based in Los Angeles, is a venture capital firm focused on the rapidly growing psychedelic medicine and mental health sector. The fund is committed to advancing research and developing innovative treatments using psychedelics to address conditions like depression, anxiety, PTSD, and other mental health issues. Mystic Ventures typically invests in pre-seed and seed-stage companies that are pioneering these therapies. Led by Jeremy Gardner and Brock Pierce, the firm takes a biotech-oriented approach, partnering with scientific research teams and pharmaceutical experts to bring cost-effective, holistic psychedelic solutions to the mainstream. With a rolling fund structure on AngelList, Mystic Ventures is uniquely positioned to offer flexible capital to startups, supporting their long-term growth in the burgeoning field of psychedelic therapeutics. The fund has backed companies like Psylo and Heading Health, among others. By investing in breakthrough treatments that go beyond traditional pharmaceutical approaches, Mystic Ventures aims to reshape how mental health treatments are developed and accessed, while offering investors exposure to this transformative market.

N49P Ventures, established in 2019 and headquartered in Toronto, Canada, focuses on seed-stage investments in Canadian technology startups. The firm primarily invests in sectors such as e-commerce, AI, fintech, and software, supporting companies with their growth and market expansion strategies. Notable portfolio companies include Visualping, which raised $6 million for its website change monitoring service, and Rally, a software company that secured $10 million in funding. N49P has also backed startups like Spellbook and EvenUp, both of which operate in the legal AI space​. The team at N49P includes founders Doug Penick, Alex Norman, and Omar Dhalla, all of whom bring extensive experience in investment and operational roles. They are actively involved in supporting their portfolio companies through fundraising, customer introductions, and ongoing coaching. N49P emphasizes building a strong community of investors who are dedicated to supporting the Canadian tech ecosystem. This community includes active founders, business executives, and exited teams who contribute their expertise and networks to help portfolio companies succeed​.

Nameless Ventures is a Chicago-based venture capital firm founded in 2017. Focused on early-stage investments, the firm actively seeks out opportunities across high-tech, enterprise software, and consumer-focused sectors. Its portfolio includes 17 companies, with notable investments in Kin, a rapidly growing insurtech unicorn, as well as PechaKucha and Nutrisense. While it has yet to make new investments in 2024, Nameless Ventures has backed ventures in sectors such as media services, healthcare, and fintech. The firm predominantly invests in the U.S., with a small footprint in Canada. Its strategy centers on seed and Series A rounds, with a preference for high-potential startups at early stages of revenue generation. Despite an average check size ranging between $2 million and $5 million, Nameless Ventures doesn’t always lead investment rounds, often partnering with co-investors like Techstars and QED Investors. Led by industry veterans Tom Firestine, Pavel Sokolovsky, and Erik Hubbard, Nameless Ventures provides a hands-on approach to its portfolio companies, leveraging expertise in marketing, product design, and supply chain management. The team is small but experienced, drawing from backgrounds in scaling consumer brands and cutting-edge tech solutions. Founders looking to connect should aim for a direct approach, highlighting strong product-market fit and scalability potential​.

Navigare Ventures, founded in 2021 and based in Stockholm, is an early-stage venture capital firm specializing in science-driven companies. As a subsidiary of Wallenberg Investments AB, Navigare Ventures focuses on deep tech sectors, including advanced computing, quantum technologies, synthetic biology, bio innovation, and data-driven life sciences. The firm is committed to investing in transformative technologies that have a strong industrial and societal impact. Navigare Ventures typically invests in Seed and Series A rounds, partnering closely with founders to support the growth and development of their companies. The firm has a robust portfolio that includes companies like Elypta, a startup developing metabolism-based liquid biopsy technology for cancer detection, and EnginZyme, which focuses on sustainable biomanufacturing. Their investment strategy is characterized by long-term partnerships, leveraging an extensive network of scientific and industrial expertise to help startups scale and succeed in their respective fields​.

NCL Technology Ventures is a UK-based venture capital firm specializing in early-stage investments across the healthcare and life sciences sectors. Founded in 2010, the firm focuses on identifying and backing companies that are driving transformational change in healthcare, with a particular emphasis on innovation in areas such as therapeutics, medical technologies, and digital health. NCL's mission is to foster companies that are developing breakthrough solutions to address global health challenges, from preventive care to cutting-edge treatments​. The firm's investments typically range between €1.5M and €3M, with a strong focus on seed and Series A funding. NCL is deeply involved in the strategic development of its portfolio companies, providing both capital and operational expertise to help them navigate the complexities of the healthcare landscape. The firm's portfolio includes companies like TC BioPharm, which is pioneering allogeneic cell therapies, and Curesponse, a precision medicine startup. With offices in London and the US, NCL is well-positioned to support its portfolio globally, fostering partnerships and driving innovation in both European and American markets. Their team, led by experienced venture capitalists like Jerry Biggs and Jonathan Synett, brings decades of investment and entrepreneurial expertise to the table.

Necessary Ventures is a San Francisco-based venture capital firm focused on investing in early-stage companies that address significant societal needs. The firm is led by Neil Devani, who brings extensive experience in both venture capital and entrepreneurship. Necessary Ventures primarily invests in companies across a range of sectors including health tech, financial services, biotechnology, and sustainability. Notable investments in their portfolio include Recursion Pharmaceuticals, a company revolutionizing drug discovery through advanced computational methods; Rubi Laboratories, which converts CO2 into sustainable textiles; and Andela, a tech talent training and employment platform. Additionally, they have backed Vicarious Surgical, which develops minimally invasive robotic surgery technology, and Wayve, an AI-driven autonomous vehicle company. The firm is known for its hands-on approach, providing not just capital but also strategic guidance and support to help their portfolio companies scale and succeed. They emphasize a collaborative and empathetic partnership with founders, aiming to create long-term value and impact. Necessary Ventures has a strong presence in both the U.S. and international markets, with investments in various high-growth regions. They have co-invested with leading venture funds such as Y Combinator, Collaborative Fund, and Talis Capital, highlighting their integration into a robust network of investors.

Neo is a venture capital firm based in San Francisco, founded by Ali Partovi, with a strong emphasis on supporting the next generation of tech leaders. Launched in 2012, Neo invests primarily in early-stage startups, often serving as the first institutional investor for many high-growth companies. Neo focuses on industries like AI, consumer internet, and education, investing in startups that have the potential to drive significant innovation. Neo’s investment strategy is centered on a hands-on approach, offering both financial backing and access to a powerful network of industry leaders. With check sizes ranging from $100K to $5 million, Neo supports startups from seed through Series A stages. They also place a high value on mentorship, connecting founders with an elite community of experienced entrepreneurs, engineers, and executives who offer guidance throughout the startup journey. The firm's portfolio includes some of the most promising startups in the tech space, such as Gusto, Pachama, and Notion. Neo prides itself on fostering diversity and inclusion, believing that the best tech companies are built by teams from a variety of backgrounds. Led by Ali Partovi and supported by a team of seasoned investors and operators, Neo is committed to making a long-term impact in the startup ecosystem by focusing on companies that combine technological innovation with meaningful social impact.

Neo Kuma Ventures, established in 2020 and headquartered in London, is Europe’s largest VC fund focused exclusively on psychedelic healthcare. Neo Kuma aims to revolutionize the treatment of mental health conditions such as depression, PTSD, addiction, and chronic pain through investments in cutting-edge psychedelic therapies. They invest in early-stage companies (Pre-Seed to Series A), deploying capital in the range of £150k to £1 million, with a particular focus on clinical research and digital therapeutics. Neo Kuma's portfolio includes significant players in the field, such as ATAI Life Sciences, Beckley Psytech, and Small Pharma, companies that are advancing the frontiers of mind-altering medicines and therapeutic platforms. Neo Kuma’s strategy is hands-on, working closely with founders to navigate both scientific development and regulatory challenges in this emerging market. The firm is led by a team of experienced investors like Clara Burtenshaw and Sean McLintock, both of whom bring a wealth of expertise in biotech, venture capital, and finance. Neo Kuma is not only a financial backer but also a policy influencer, collaborating with leading organizations in psychedelic research, such as the International Therapeutic Psilocybin Rescheduling Initiative. This integrated approach positions Neo Kuma as a key player in reshaping the future of mental healthcare through psychedelics.

Neotribe Ventures, founded in 2017 and based in Menlo Park, California, is a venture capital firm that focuses on investing in breakthrough technologies across various sectors including applied artificial intelligence, biotech, enterprise infrastructure, and the internet of things. The firm targets early to growth-stage companies that are shaping the future through innovative solutions. Neotribe Ventures has made 98 investments with notable companies in its portfolio such as Energy Vault, Heliogen, and CipherTrace. The firm has achieved 17 exits, including significant companies like Robinhood, which went public in July 2021. Other successful exits include Pluribus Networks and ClearMotion. The firm is led by co-founders Swaroop Kolluri and Steven Bragonier, along with partners like Nitin Chopra and Neeraj Hablani. Neotribe Ventures manages nearly $450 million in assets across three funds, including the recent Ignite Fund, which focuses on growth-stage investments. Neotribe Ventures' strategy involves providing not just capital but also extensive support and resources to help their portfolio companies succeed. The firm's emphasis on deep technology and innovative solutions makes it a significant player in the venture capital landscape​.

Neulogy Ventures, established in 2014 and based in Bratislava, Slovakia, is a Luxembourg-regulated venture capital fund. The firm focuses on early-stage tech companies, particularly those operating in Slovakia and the Central and Eastern Europe (CEE) region. Neulogy Ventures manages €65 million in assets, with a diverse portfolio spread across 10 countries. The fund targets investments in sectors like media, cleantech, data analytics, productivity applications, medtech, infrastructure, fintech, security, 3D, e-commerce, and new energy. Neulogy Ventures aims to support mission-driven entrepreneurs with bold ideas that push technological frontiers, particularly those addressing climate change and healthcare challenges. Neulogy Ventures emphasizes a hands-on approach, offering strategic guidance, business development support, and fundraising assistance to its portfolio companies. The firm values long-term partnerships, prioritizing shared values and a collaborative approach over quick exits. Notable companies in Neulogy's portfolio include GA Drilling, GreenWay, and GroupSolver. The team, led by managing partners Christian Mandl and Jaroslav Luptak, brings extensive experience in entrepreneurship, fundraising, and business development, ensuring robust support for their investees.

Neva SGR, founded in 2020, is the venture capital arm of Intesa Sanpaolo Group, one of Italy's largest banking institutions. Based in Turin, Neva focuses on investing in technology-driven companies at various stages, from seed to Series C. The firm is sector-agnostic but leans heavily towards fintech, deeptech, ESG transition technologies, and core tech innovations. With two main funds—Neva First and Neva First Italia—the firm targets both Italian and international startups. Neva First focuses on global opportunities, with a minimum of 30% invested in Italian companies, while Neva First Italia co-invests with a more localized emphasis on Italian startups. The funds have a combined budget of around €500 million, with an average ticket size of €4-10 million per investment. Neva SGR is particularly active in life sciences and deeptech, with notable portfolio companies including D-Orbit in space logistics and Tr1X, a biotech firm focused on autoimmune therapies. The firm’s mission is to foster innovation that addresses global challenges while boosting the Italian and European tech ecosystems.

New Enterprise Associates (NEA) is a global venture capital firm with a storied history of supporting innovative businesses. Founded in 1977, NEA manages over $25 billion in assets and invests across all stages of a company's lifecycle, from seed stage to IPO. The firm has a diverse portfolio that spans technology and healthcare sectors. NEA's notable investments include companies like 23andMe, Coursera, Robinhood, and Uber, highlighting their focus on transformational businesses. They have facilitated over 270 IPOs and more than 450 mergers and acquisitions, underscoring their impact on the market. The firm operates from key locations in Menlo Park, California, and New York City, but their investment reach is global, covering North America, Europe, Asia, and beyond. NEA's strategy involves not just funding but also actively mentoring and supporting their portfolio companies through various stages of growth. Recently, NEA closed on two new funds totaling $6.2 billion, the largest in the firm's history, aimed at early-stage and growth-stage investments in sectors like enterprise tech, fintech, digital health, and life sciences. This reflects NEA’s commitment to driving innovation and supporting founders with the capital and expertise needed to build successful companies.

NLV Partners, founded in 2005, is a leading venture capital firm focused on revolutionizing healthcare. With notable investments in companies like CRISPR Therapeutics, Akili Interactive Labs, and iRhythm Technologies, NLV Partners targets biopharmaceuticals, diagnostics, medical devices, and healthcare IT. Their portfolio boasts 30 billion-dollar companies and numerous successful exits, reflecting their impact in the industry. Geographically, NLV Partners concentrates on the United States, partnering with businesses from startup stages to public offerings. Their investment strategy involves backing visionary teams and disruptive healthcare technologies. They aim to develop commercially attractive and clinically important healthcare solutions, leveraging decades of experience and deep domain expertise to navigate the complex healthcare landscape. NLV Partners typically leads investment rounds, providing not only capital but also strategic guidance. They prefer to be approached through well-prepared pitches that clearly demonstrate the potential for clinical and commercial success. The fund's average check size varies, tailored to the needs of each investment. The team includes co-founders Ron Hunt and Vijay Lathi, based in New York and Menlo Park respectively. Both bring extensive experience in healthcare investments and have been instrumental in shaping the firm's strategic direction. For startups seeking a partner with profound industry knowledge and a track record of success, NLV Partners stands out as a pivotal ally in the healthcare sector.

VisVires New Protein, recently rebranded as Clay Capital, is a Singapore-based venture capital firm dedicated to transformative investments in the agrifood tech sector. Founded in 2014, Clay Capital focuses on supporting innovative startups that address fundamental challenges in the food system, particularly in the areas of sustainable packaging, fermentation, agricultural biologicals, crop disease resistance, soil health, and regenerative agriculture. Notable investments include French biostimulant producer Toopi, Israeli bioherbicide startup WeedOUT, and French kitchen robot manufacturer Cook-e. These investments reflect Clay Capital's commitment to leveraging technology to improve sustainability and efficiency in the food and agriculture sectors. Clay Capital's strategy involves investing in early-stage to growth-stage startups, typically with initial checks ranging from $3 million to $8 million, and reserving additional capital for follow-on investments. The firm serves as a bridge between the Asian and European markets, providing startups with support to access and expand in these regions. The rebranding from VisVires New Protein to Clay Capital signifies a renewed focus on building a healthy and sustainable food system, symbolizing fertile ground for growth and innovation. With a newly raised $145 million fund, Clay Capital is well-positioned to continue driving impactful changes in the agrifood tech landscape

New Science Ventures (NSV) is a premier venture capital firm established in 2004, with offices in New York and London. The firm specializes in investing in companies that leverage groundbreaking scientific innovations in the life sciences and information technology sectors. NSV has a keen focus on businesses with strong IP protection and those addressing significant unmet market needs. Notable investments include Ventyx Biosciences, Phase Four, Achronix Semiconductor, and Paragraf. NSV is particularly interested in companies that can transform their industries with innovative scientific approaches. Their strategy is to invest in both early and mid-stage companies, supporting them through crucial growth phases to maximize their potential and value. NSV is not afraid to take contrarian views and often seeks opportunities outside traditional tech hubs, emphasizing the importance of science-based innovation. The firm typically leads funding rounds and provides substantial follow-on support, ensuring that their portfolio companies have the resources needed to succeed. Key team members include co-founder Tom Lavin, who brings over 30 years of experience in finance and investment banking, and Raju Mohan, a seasoned biotech entrepreneur and senior advisor with extensive expertise in drug discovery and development. Startups looking to engage with NSV should emphasize their scientific uniqueness and potential for significant market impact. NSV values strong management teams and clear, defensible IP strategies, making these essential points of focus when approaching the firm.

NewSpring Capital, founded in 1999 and headquartered in Radnor, Pennsylvania, is a private equity firm focusing on growth equity, mezzanine capital, healthcare, and buyouts. The firm manages approximately $3.5 billion in assets and has invested in over 250 companies across various sectors. Notable investments in NewSpring's portfolio include Vacasa, a leading vacation rental management company; Innovid, a video marketing platform; and Nutrisystem, a weight management company. These investments reflect NewSpring's strategy of supporting high-growth companies in business services, healthcare, information technology, and consumer products. NewSpring Capital operates through multiple strategies, including NewSpring Growth, which targets high-growth technology companies; NewSpring Healthcare, focusing on innovative healthcare services and technology; and NewSpring Mezzanine, providing capital for acquisitions and recapitalizations. The firm's comprehensive approach allows them to support companies at different stages of their lifecycle, from early growth to expansion.

New Stack Ventures is an early-stage venture capital firm focused on investing in founders who are often overlooked by traditional venture capital firms. Founded by Nick Moran, New Stack Ventures targets startups in under-capitalized markets and geographies, with a particular focus on IoT, deep tech, smart hardware, and various platform-based business models. The firm recently closed its second fund, New Stack Ventures Fund II, at $42.6 million, significantly larger than its first $6 million fund. This new fund allows New Stack to support an additional 35 companies at the pre-seed and seed stages. The firm prides itself on being one of the largest single-partner funds raised outside of the typical Silicon Valley ecosystem, emphasizing its commitment to backing "outsider" founders. New Stack Ventures has built a strong reputation for its proactive and founder-friendly approach. The firm was highlighted by TechCrunch as one of the most active and engaged investors in the industry. Its portfolio includes notable companies like Draftbit, Curv, and Flamingo, reflecting its diverse investment strategy. The team at New Stack Ventures is comprised of experienced professionals, including Nate Pierotti, Luke Skertich, and Ariella Frank, who bring extensive backgrounds in startups, product management, and venture capital. Their collaborative and inclusive investment process ensures they identify and support high-potential startups effectively.

New York Angels, founded in 2004, is one of the most active and well-established angel investor groups based in New York City. Specializing in early-stage investments, the group has made over 386 investments, with notable successes including Greenhouse Software, Payoneer, and Billtrust. Their portfolio spans various sectors such as Artificial Intelligence, Fintech, Healthcare, and SaaS. New York Angels typically invests in increments starting from $25,000 and expects its members to invest a minimum of $50,000 annually in its deals. Their average investment round size is around $2 million, and they are known for both leading and participating in follow-on rounds. The group has achieved 72 exits, indicating a strong track record of identifying and nurturing high-potential startups. The investment strategy of New York Angels emphasizes thorough due diligence and a collaborative approach, leveraging the diverse expertise of its members. They actively engage with their portfolio companies, providing not only capital but also valuable mentorship and networking opportunities. Key figures in the organization include founder David S. Rose, who has played a pivotal role in shaping the group's investment philosophy and operations. Startups looking to secure funding from New York Angels should be prepared to demonstrate strong business fundamentals and a clear growth trajectory

Empire State Development (ESD) is New York State's chief economic development agency, focusing on promoting business growth, job creation, and enhancing the state’s overall economy. Through various programs and initiatives, ESD supports businesses of all sizes and industries, providing financial incentives, grants, loans, and other resources to foster economic development across the state. One of ESD's flagship programs is the "FAST NY" initiative, which aims to create shovel-ready sites for industrial development, providing substantial grants to improve infrastructure like transportation, utilities, and site development. This program has committed over $175 million to support over 2,700 acres of industrial property. ESD is also a major player in fostering innovation through investments in life sciences and biotech. For instance, the expansion of Harlem Biospace, supported by a $1.5 million ESD grant, exemplifies its role in nurturing New York’s biotech ecosystem by providing advanced facilities for startups and fostering collaboration between businesses and academic institutions like Columbia University. Overall, ESD’s initiatives are focused on strategic job creation, attracting innovative industries, and revitalizing communities, helping to position New York as a competitive environment for both startups and established businesses.